Inpatient Chemotherapy Service Improvement Project (#203)
3:00 PM
Quit Or Quiet? High Smoking Prevalence, Low Disclosure Rates and Low Smoking Cessation Program Participation Rates among Cancer Patients (#204)
3:00 PM
Palliative Car Referrals and Time Period between Last Chemotherapy and Death in Metastatic Breast Cancer Patients in North Queensland. (#205)
3:00 PM
Cancer Coping Online: Findings and lessons learned from a phase II RCT of an eHealth program for reducing cancer-distress. (#206)
3:00 PM
COSA Position Statement - The Use of Complementary and Alternative Medicine by Cancer Patients (#210)
3:00 PM
Analysis of Pharmacist role in Haematology and Oncology at Royal Darwin Hospital (#211)
3:00 PM
Identifying and addressing the supportive care needs of the ‘complex’ patient with Multiple Myeloma within a Nurse Practitioner led service (#212)
3:00 PM
Victorian Patient Management Framework: Achievements and future directions (#213)
3:00 PM
Navigating Indirect Utility Models in Cancer: Mapping the EORTC QLQ-C30 onto the EQ-5D (#214)
3:00 PM
Assessing the Value of Precision Therapies in the Multi-Omics Era of Medicine (#215)
3:00 PM
Community Oncology: Patients’ perspective on a rural Australian medical oncology outreach service (#216)
3:00 PM
Feasibility study of an oncology nurse practitioner model of care in a rural cancer setting (#217)
3:00 PM
Service Mapping the Flow of Care for Chemotherapy Outpatients at Sir Charles Gairdner Hospital (#218)
3:00 PM
Development and implementation of a clinical cancer data collection system in WA (#220)
3:00 PM
How acceptable and beneficial do clinicians think peer review of multidisciplinary cancer teams is? (#221)
3:00 PM
Is the chemo ready yet?! Gaining efficiency in parenteral cancer chemotherapy supply at a large tertiary level hospital (#223)
3:00 PM
Where to care for childhood cancer survivors? Survivor and oncology service provider perspectives (#224)
3:00 PM
Radiotherapy access in the West Hume region: any need for a local radiation facility? (#225)
3:00 PM
Risk perception in medical imaging: Understanding the effect of two risk presentation formats on knowledge (#226)
3:00 PM
Forthcoming Prognostic Markers for Oesophageal Cancer: A Systematic Review and Meta-Analysis (#227)
3:00 PM
An exploration of the relationship between funding and patient accrual to oncology clinical trials: Additional Funding Intervention Trial (AFIT) (#228)
3:00 PM
An Estimate of the Rate of Participation by Adolescent and Young Adults (AYA) in Oncology Clinical Trials in Victoria: 2011 and 2012 (#229)
3:00 PM
Celebrating 25 years of the Clinical Trials Management Scheme (CTMS): Victorian clinical trial activity, 1988-2013 (#230)
3:00 PM
Mapping cancer pain screening, assessment and reassessment practices within one Australian health district: results from a baseline chart audit (#231)
3:00 PM
Exploring opiate errors in the specialist cancer and palliative care setting: perceptions of key stakeholders (#232)
3:00 PM
An Evidence-Based Estimation of Local Control and Survival Benefit of Radiotherapy for Colorectal Cancer (#233)
3:00 PM
Peer Review of Multidisciplinary cancer teams: a pilot study (#234)
3:00 PM
It’s Not Just a Numbers Thing – Looking for Quality in MDMs (#235)
3:00 PM
Indigenous Patients with Metastatic Lung Cancer at the Royal Darwin Hospital: An Eleven Year Audit of Data Regarding Chemotherapy, Radiotherapy and Palliative Care. (#236)
3:00 PM
Assessing cancer patients experiences of care: the Victorian experience. (#238)
3:00 PM
Development of a capability framework to support the provision of chemotherapy within a shared care model for children and adolescents with cancer (#239)
3:00 PM
Working Together: An Integrated Model of Care for Cancer Services (#240)
3:00 PM
The Challenges in Integrating Care Coordinators into Cancer Care – an Analysis of Australian Evaluation Data (#241)
3:00 PM
Does the Availability of a Local Service Change the Types of Patients Who Accesses Radiotherapy? An Investigation in the Western NSW Local Health District (WNSWLHD). (#242)
3:00 PM